2,6-Di-tert-butylphenol and its quinone metabolite trigger aberrant transcriptional responses in C57BL/6 mice liver

Shixuan Cui,Yang Yu,Tingjie Zhan,Chunlong Zhang,Shulin Zhuang
DOI: https://doi.org/10.1016/j.scitotenv.2021.146322
2021-07-01
Abstract:<p>2,6-Di-<em>tert</em>-butylphenol (2,6-DTBP) is used as an antioxidant with wide commercial applications and its residues have been detected in various environmental matrices. 2,6-DTBP may enter human body <em>via</em> ingestion, inhalation or other exposure pathways. However, its susceptibility to biotransformation and potential of the metabolic products to trigger aberrant transcriptional responses remain unclear. Here, we investigated <em>in vitro</em> and <em>in vivo</em> biotransformation of 2,6-DTBP and characterized the RNA-Seq based transcriptional profiling of C57BL/6 mice liver after the exposure to 2,6-DTBP and its metabolites. 2,6-DTBP was metabolized into hydroxylated (2,6-DTBH) and <em>para</em>-quinone (2,6-DTBQ) products with residues detected in serum and liver of C57BL/6 mice. 2,6-DTBP and 2,6-DTBQ induced the aberrant transcription in C57BL/6 mice liver featured with 373–2861 differentially expressed genes (DEGs). They also up-regulated 1.09–2.92 fold mRNA expression of carcinogenesis-related genes such as <em>Ccnd1</em>, <em>TGFβ1</em> and <em>FOS</em> in C57BL/6 mice liver. Our study indicated potential carcinogenic risk of 2,6-DTBP and its metabolites, beneficial to further evaluation of health risk of TBPs-related contaminants.</p>
environmental sciences
What problem does this paper attempt to address?